Is AngioDynamics Inc (ANGO) overvalued? · rev $292.5M
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
This page asks whether AngioDynamics Inc (ANGO) looks expensive on cached numbers — not a short thesis.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
ANGO currently screens at market cap $378.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ANGO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ANGO stock page for the full model, not this heading.
Not investment advice.